MEDICAMEN Biotech has constantly strived to be on the path of growth on the strength of its brilliant human resource, world class facilities and a global vision of its Management.
From being a purely Formulation manufacturer of general products, the Company has diversified into setting up a state-of-the-art R&D Centre followed by a most modern API manufacturing facility and, lastly, setting up a highly auditable facility for manufacturing Oncology injectables and OSDs which will stand the test of leading global regulatory agencies. Please find below our journey from humble beginnings to being a vertically integrated Group:
IPO issued – BSE listed.
Operations started - Bhiwadi FDF Plant
WHO-GMP Received – Bhiwadi FDF Plant
ISO certification – Bhiwadi FDF Plant
NDA(Uganda), ANVISA(Brazil),FM HACA( Ethiopia)-Bhiwadi FDF Plant
Operations started – Haridwar Unit-I (FDF)
New R&D center setup along with Upgradation & Mordernization of Bhiwadi FDF plant
Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd
FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant
Global API Facility started– Dahej API Plant
Operations started: Haridwar formulation Unit –II(FDF) (oncology)
Filing API USDMFs & CEPs